EBITDA

The Geneva Association recognizes Elena Sanz for her exceptional leadership, blending a human-focused strategy with decisive action during recent crises.

With $266M and 300MW of secured power, HighBrook Investors is tackling Northern Virginia's data center shortage, signaling a major PE shift.

Select Medical's take-private deal at $16.50/share faces scrutiny as law firms question if shareholders are getting fair value from an insider-led group.

The world's largest equity derivatives clearing house is overhauling its core tech, tapping a FinTech innovator for a critical risk management upgrade.

A novel oral drug for Alzheimer's avoids a key side effect of current therapies, as its 'detangler' platform shows promise for Parkinson's and other diseases.

A new strategic partnership between AlbaCore and MUFG aims to unlock billions for UK and European infrastructure, offering investors access to stable returns.

Irish Continental Group posts a 10.4% revenue surge and record profits, driven by freight, but faces scrutiny over a sharp rise in debt and port issues.

A Chinese firm's innovative probiotic packaging just won a top design award, solving a key industry problem and signaling a new era for 'Made in China'.

ST's new STM32C5 microcontroller series promises to bring high-end performance and robust security to billions of cost-sensitive smart devices.

CrowdStrike and Schwarz Digits partner to deliver AI-native security on a sovereign EU cloud, answering Europe's call for data control amid new regulations.

German defense tech firm RENK Group reports a record €1.37B revenue, fueled by a 24% surge in its defense business amid global geopolitical tensions.

Phonak's new hearing aids won a top design award, blending advanced AI with discreet style to change how we see and hear with assistive technology.

Despite a tough 2025, Janus International's Q4 profit jump and 2026 growth forecast signal a strategic pivot driven by smart tech and a key acquisition.

The staffing firm saw revenue fall 22% and posted a $95M net loss in 2025, now pivoting to its tech platform and cost cuts for a comeback.

The energy services firm surpassed analyst expectations with strong revenue growth and a key acquisition, but warns of a challenging year ahead.

With a unique entry-blocking drug, Bioxytran targets COVID, flu, and RSV, moving toward a pivotal trial that could redefine antiviral treatment.

At PDAC 2026, Italy and Canada solidified a strategic partnership for critical minerals, powered by Italian technology and a new digital trade platform.

A new AI-powered app and brand shield aim to end consumer confusion over ultra-processed foods, pushing for industry-wide transparency and reformulation.

As AI stalls on unstructured data, Sanity's new Content Operating System promises to provide the structured foundation needed for AI to reason, not just guess.

Svitla Systems lands on the 2026 IAOP Global Outsourcing 100 list, recognized for its AI innovation, 90% client retention, and responsible growth.